CD4+ T cell-mediated cytotoxicity toward thyrocytes: The importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone

Laboratory Investigation

Volumn 80, Issue 4, 2000, Pages 471-484

  Kawakami, Atsushi ^a   Matsuoka, Naoki ^a   Tsuboi, Masahiko ^a   Koji, Takehiko ^a   Urayama, Satoshi ^a   Sera, Nobuko ^a   Hida, Ayumi ^a   Usa, Toshiro ^a   Kimura, Hironori ^a   Yokoyama, Naokata ^a   Nakashima, Tomoki ^a   Ishikawa, Naofumi ^b   Ito, Kunihiko ^b   Kawabe, Yojiro ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ITO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL HYPERPLASIA; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; GRAVES DISEASE; HORMONE INHIBITION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYROID GLAND;

EID: 0034104236     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780053     Document Type: Article

References (43)

1. + T lymphocytes. J Immunol 144:574-582.
2. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, and Somoza C (1993). B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76-79.
3. Bohmig GA, Kovarik J, Holter W, Pohanka E, and Zlabinger GJ (1994). Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol 152:3720-3728.
4. + T lymphocytes. J Immunol 148:1985-1992.
5. Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, and Ben-Nun A (1991a). Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 325:238-244.
6. Davies TF, Martin A, Concepcion ES, Graves P, Lahat N, Cohen WL, and Ben-Nun A (1991b). Evidence for selective accumlation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. J Clin Invest 89:157-162.
7. De Groot LJ, Larsen PR, and Hennemann G (1996). Thyroid hormone synthesis and secretion. In: De Groot LJ, Larsen PR, and Hennemann G, editors. The thyroid and its diseases. New York: Churchill Livingstone Inc., 33-60.
8. Dumont JE (1971). The action of thyrotropin on thyroid metabolism. Vitam Horm 29:287-412.
9. Eguchi K, Matsuoka N, and Nagataki S (1995). Cellular immunity in autoimmune thyroid disease. Baillieres Clin Endocrinol Metab 9:71-94.
10. Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Ueki Y, Nakao H, Tezuka H, Matsunaga M, Fukuda T, Ishikawa N, Ito K, and Nagataki S (1988). Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease. Clin Exp Immunol 72:84-90.
11. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, and Nadler LM (1993). Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909-911.
12. Giordano C, Stassi G, DeMaria RD, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, and Galluzzo A (1997). Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963.
13. Hakuno N, Koji T, Yano T, Kobayashi N, Tsutsumi O, Taketani Y, and Nakane PK (1996). Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 137:1938-1948.
14. Hammond LJ, Lowdell MW, Cerrano PG, Goode AW, Bottazzo GF, and Mirakian R (1997). Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. J Pathol 182:138-144.
15. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, and Ley TJ (1994). Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977-987.
16. Ishikawa N, Eguchi K, Otsubo T, Ueki Y, Fukuda T, Tezuka H, Matsunaga M, Kawabe Y, Shimomura C, Izumi M, Ban Y, Ito K, and Nagataki S (1987). Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. J Clin Endocrinol Metab 65:17-23.
17. Ishikawa N, Eguchi K, Ueki Y, Nakashima M, Shimada H, Ito K, and Nagataki S (1993). Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease. Clin Exp Immunol 94:363-370.
18. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, and Nagata S (1991). The polypeptide encoded by the cDNA for human cell surface Fas can mediate apoptosis. Cell 66:233-243.
19. + cytotoxic T cells. Proc Natl Acad Sci USA 91:4185-4189.
20. Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y, Tezuka H, Nakao H, Kawakami A, Migita K, Yamashita S, Matsunaga M, Ishikawa N, Ito K, and Nagataki S (1989). Interleukin-1 production and action in thyroid tissue. J Clin Endocrinol Metab 68:1174-1183.
21. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N, Ito K, and Nagataki S (1996). Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 137:3163-3169.
22. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, Fujiyama K, Kiriyama T, Nakashima T, Nakane PK, and Nagataki S (1997a). Fas and Fas Ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 12:1637-1646.
23. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Urayama S, Kawabe Y, Tahara K, Ishikawa N, Ito K, and Nagataki S (1997b). Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxedema. Clin Exp Immunol 110:434-439.
24. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Sumida T, and Nishioka K (1999). Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells. Arthritis Rheum 42:519-526.
25. Lan L and Wong N-S (1999). Phosphatidylinositol 3-kinase and protein kinase C are required for the inhibition of caspase activity by epidermal growth factor. FEBS Lett 444:90-96.
26. Marrack P and Kapper J (1990). The staphylococcal enterotoxins and their relatives. Science 248:705-711.
27. Matsuoka N, Eguchi K, Kawakami A, Tsuboi M, Nakamura H, Kimura H, Ishikawa N, Ito K, and Nagataki S (1996). Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells. J Clin Endocrinol Metab 81:4137-4143.
28. Nagata S (1997). Apoptosis by death factor. Cell 88:355-365.
29. Nagata S and Golstein P (1995). The Fas death factor. Science 267:1449-1456.
30. Nagataki S and Eguchi K (1992). Cytokines and immune regulation in thyroid autoimmunity. Autoimmunity 13:27-34.
31. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, and Riccardi C (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279.
32. Ozdemirli M, El-Khatib M, Foote LC, Wang JKM, Marshak-Rothstein A, Rothstein TL, and Ju ST (1996). Fas(CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses. Eur J Immunol 26:415-419.
33. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, and Ashkenazi A (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690.
34. +)-independent T cell-mediated cytotoxicity. J Exp Med 177:195-200.
35. Seth A, Stern LJ, Ottenhoff TH, Engel I, Owen MJ, Lamb JR, Klausner RD, and Wiley DC (1994). Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 369:324-327.
36. + T cell-mediated cytotoxicity. J Immunol 152:1127-1133.
37. Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, and Ota Z (1995). Apoptosis in thyroid diseases: a histochemical study. Endocr J 42:193-201.
38. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
39. Tian Q, Streuli M, Saito H, Schlossman SF, and Anderson P (1991). A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67:629-639.
40. + T cells against staphylococcal enterotoxin B-pulsed endothelial cells. Biochem Biophys Res Commun 239:782-788.
41. Valente WA, Vitti P, Kohn LD, Brandi ML, Rotella CM, Toccafondi R, Tramontano D, Aloj SM, and Ambesi-Impiombato FS (1983). The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology 112:71-79.
42. Wadeleux PA and Winard RJ (1981). Some unexpected effects of thyrotrophin on the metabolism of thyroid cells isolated from non-toxic goitre. Acta Endocrinol (Copenh) 98:533-539.
43. Westermark B, Karlsson FA, and Walinder O (1979). Thyrotropin is not a growth factor for human thyroid cells in culture. Proc Natl Acad Sci USA 76:2022-2026.